Multimodal metabolic imaging of cerebral gliomas: Positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy

Journal of Neurosurgery

Volumn 102, Issue 2, 2005, Pages 318-327

  Floeth, Frank Willi ^a   Pauleit, Dirk ^b   Wittsack, Hans Jörg ^b   Langen, Karl Josef ^b   Reifenberger, Guido ^b   Hamacher, Kurt ^b   Messing Jünger, Martina ^b   Zilles, Karl ^b   Weber, Friedrich ^b   Stummer, Walter ^b   Steiger, Hans Jakob ^b   Woebker, Gabriele ^b   Müller, Hans Wilhelm ^b   Coenen, Heinz ^b   Sabel, Michael ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b NONE

Author keywords

18F fluoroethyl l tyrosine; Amino acid positron emission tomography; Biopsy; Glioma; Magnetic resonance spectroscopy

Indexed keywords

CHOLINE; FLUOROETHYL TYROSINE F 18; N ACETYLASPARTIC ACID; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; ASPARTIC ACID; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FLUORINE; N-ACETYLASPARTATE; O (2 FLUOROETHYL)TYROSINE; O-(2-FLUOROETHYL)TYROSINE; TYROSINE;

ADULT; AGED; ARTICLE; BRAIN METABOLISM; CANCER DIAGNOSIS; CHILD; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG UPTAKE; FEMALE; GLIOMA; HISTOLOGY; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NEURONAVIGATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; TUMOR BIOPSY; ADOLESCENT; BIOPSY; BRAIN; BRAIN TUMOR; ENERGY METABOLISM; IMAGE PROCESSING; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; ASPARTIC ACID; BIOPSY; BRAIN; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; CHOLINE; ENERGY METABOLISM; FEMALE; FLUORINE RADIOISOTOPES; GLIOMA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEURONAVIGATION; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TYROSINE;

EID: 14844320869     PISSN: 00223085     EISSN: 00223085     Source Type: Journal    
DOI: 10.3171/jns.2005.102.2.0318     Document Type: Article

References (61)

1. Bernstein M, Parrent AG: Complications of CT-guided stereotactic biopsy of intra-axial brain lesions. J Neurosurg 81:165-168, 1994
2. Bottomley PA: Spatial localization in NMR spectroscopy in vivo. Ann NY Acad Sci 508:333-348, 1987
3. Braun V, Dempf S, Weller R, Reske SN, Schachenmayr W, Richter HP: Cranial neuronavigation with direct integration of (11)C methionine positron emission tomography (PET) data - results of a pilot study in 32 surgical cases. Acta Neurochir 144:777-782, 2002
4. Burger PC, Heinz ER, Shibata T, Kleihues P: Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J Neurosurg 68:698-704, 1988
5. Chandrasoma PT, Smith MM, Apuzzo ML: Stereotactic biopsy in the diagnosis of brain masses: comparison of results of biopsy and resected surgical specimen. Neurosurgery 24:160-165, 1989
6. 18F-FDG PET. Eur J Nucl Med Mol Imaging 29:176-182, 2002
7. Derlon JM, Chapon F, Noel MH, Khouri S, Benali K, Petit-Taboue MC, et al: Non-invasive grading of oligodendrogliomas: correlation between in vivo metabolic pattern and histopathology. Eur J Nucl Med 27:778-787, 2000
8. 18F-fluorodeoxyglucose and 11C-L-methylmethionine. Neurosurgery 40:276-288, 1997
9. De Witte O, Goldberg I, Wikler D, Rorive S, Damhaut P, Monclus M, et al: Positron emission tomography with injection of methionine as a prognostic factor in glioma. J Neurosurg 95:746-750, 2001
10. Dowling C, Bollen AW, Noworolski SM, McDermott MW, Barbaro NM, Day MR, et al: Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. AJNR 22:604-612, 2001
11. Duijn JH, Matson GB, Maudsley AA, Weiner MW: 3D phase encoding 1H spectroscopic imaging of human brain. Magn Reson Imaging 10:315-319, 1992
12. Edner G: Stereotactic biopsy of intracranial space occupying lesions. Acta Neurochir 57:213-234, 1981
13. Fulham MJ, Bizzi A, Dietz MJ, Shih HH, Raman R, Sobering GS, et al: Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology 185:675-686, 1992
14. Goldman S, Levivier M, Pirotte B, Brucher JM, Wikler D, Damhaut P, et al: Regional glucose metabolism and histopathology of gliomas. A study based on positron emission tomography-guided stereotactic biopsy. Cancer 78:1098-1106, 1996
15. Goldstein S, Gumerlock MK, Neuwelt EA: Comparison of CT-guided and stereotaxic cranial diagnostic needle biopsies. J Neurosurg 67:341-348, 1987
16. Grosu AL, Weber W, Feldmann HJ, Wuttke B, Bartenstein P, Gross MW, et al: First experience with I-123-alpha-methyl-tyrosine spect in the 3-D radiation treatment planning of brain gliomas. Int J Radiat Oncol Biol Phys 47:517-526, 2000
17. 18F) fluoroethyl-L-tyrosine. Appl Radiat Isot 57:853-856, 2002
18. Hamilton RJ, Sweeney PJ, Pelizzari CA, Yetkin FZ, Holman BL, Garada B, et al: Functional imaging in treatment planning of brain lesions. Int J Radiat Oncol Biol Phys 37:181-188, 1997
19. Hayashi T, Kumabe T, Jokura H, Fujihara K, Shiga Y, Watanabe M, et al: Inflammatory demyelinating disease mimicking malignant glioma. J Nucl Med 44:565-569, 2003
20. 18F]fluoroethyl)-L-tyrosine in vitro and in vivo. J Nucl Med 40:1367-1373, 1999
21. Herholz K, Holzer T, Bauer B, Schroder R, Voges J, Ernestus RI, et al: 11C-methionine PET for differential diagnosis of low-grade gliomas. Neurology 50:1316-1322, 1998
22. Jager PL, Vaalburg W, Pruim J, de Vries EG, Langen KJ, Piers DA: Radiolabeled amino acids: basic aspects and clinical applications in oncology. J Nucl Med 42:432-445, 2001
23. 18F] fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumors. Ann Neurol 33:540-548, 1993
24. Kaim AH, Weber B, Kurrer MO, Westera G, Schweitzer A, Gottschalk J, et al: (18)F-FDG and (18)F-FET uptake in experimental soft tissue infection. Eur J Nucl Med Mol Imaging 29:648-654, 2002
25. Kaschten B, Stevenaert A, Sadzot B, Deprez M, Degueldre C, Del Fiore G, et al: Preoperative evaluation of 54 gliomas by PET with fluorine-18- fluorodeoxyglucose and/or carbon-11-methionine. J Nucl Med 39:778-785, 1998
26. Kinoshita Y, Kajiwara H, Yokota A, Koga Y: Proton magnetic resonance spectroscopy of brain tumors: an in vitro study. Neurosurgery 35:606-614, 1994
27. Kleihues P, Cavenee WK (eds): World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Nervous System. Lyon: IARC Press, 2000
28. 11C]-l-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma. Eur J Nucl Med Mol Imaging 30:868-873, 2003
29. Kreth FW, Muacevic A, Medele R, Bise K, Meyer T, Reulen HJ: The risk of haemorrhage after image guided stereotactic biopsy of intra-axial brain tumours - a prospective study. Acta Neurochir 143:539-546, 2001
30. Langen, KJ: Amino acid transport studies in brain tumors, in Feinendegen LE, Shreeve WW, Eckelman WC, et al (eds): Molecular Nuclear Medicine: The Challenge of Genomics and Proteomics to Clinical Practice. Berlin: Springer-Verlag, 2003, pp 477-485
31. Langen KJ, Jarosch M, Muhlensiepen H, Hamacher K, Broer S, Jansen P, et al: Comparison of fluorotyrosines and methionine uptake in F98 rat gliomas. Nucl Med Biol 30:501-508, 2003
32. Law M, Yang S, Wang H, Babb JS, Johnson G, Cha S, et al: Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR 24:1989-1998, 2003
33. Lunsford LD, Somaza S, Kondziolka D, Flickinger JC: Brain astrocytomas: biopsy, then irradiation. Clin Neurosurg 42:464-479, 1995
34. Maciunas RJ, Kessler RM, Maurer C, Mandava V, Watt G, Smith G: Positron emission tomography imaging-directed stereotactic neurosurgery. Stereotact Funct Neurosurg 58:134-140, 1992
35. Massager N, David P, Goldman S, Pirotte B, Wikler D, Salmon I, et al: Combined magnetic resonance imaging- and positron emission tomography-guided stereotactic biopsy in brainstem mass lesions: diagnostic yield in a series of 30 patients. J Neurosurg 93:951-957, 2000
36. Matsukado Y, MacCarty CS, Kernohan JW: The growth of glioblastoma multiforme (astrocytomas, grades 3 and 4) in neurosurgical practice. J Neurosurg 18:636-644, 1961
37. McGirt MJ, Villavicencio AT, Bulsara KR, Friedman AH: MRI-guided stereotactic biopsy in the diagnosis of glioma: comparison of biopsy and surgical resection specimen. Surg Neurol 59: 277-282, 2003
38. McKnight TR, von dem Bussche MH, Vigneron DB, Lu Y, Berger MS, McDermott MW, et al: Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence. J Neurosurg 97:794-802, 2002
39. Messing-Junger AM, Floeth FW, Pauleit D, Reifenberger G, Willing R, Gartner J, et al: Multimodal target point assessment for stereotactic biopsy in children with diffuse bithalamic astrocytomas. Childs Nerv Syst 18:445-449, 2002
40. Michaelis T, Merboldt KD, Bruhn H, Hanicke W, Frahm J: Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology 187:219-227, 1993
41. Negendank WG, Sauter R, Brown TR, Evelhoch JL, Falini A, Gotsis ED, et al: Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg 84:449-458, 1996
42. 1H MRSI. NMR Biomed 12:123-138, 1999
43. Nuutinen J, Sonninen P, Lehikoinen P, Sutinen E, Valavaara R, Eronen E, et al: Radiotherapy treatment planning and long-term follow-up with [(11)C]methionine PET in patients with low-grade astrocytoma. Int J Radiat Oncol Biol Phys 48:43-52, 2000
44. Ogawa T, Shishido F, Kanno I, Inugami A, Fujita H, Murakami M, et al: Cerebral glioma: evaluation with methionine PET. Radiology 186:45-53, 1993
45. Oppitz U, Maessen D, Zunterer H, Richter S, Flentje M: 3D-recurrence-patterns of glioblastomas after CT-planned postoperative irradiation. Radiother Oncol 53:53-57, 1999
46. Ostertag CB, Mennel HD, Kiessling M: Stereotactic biopsy of brain tumors. Surg Neurol 14:275-283, 1980
47. 18F] fluoroethyl)-L-tyrosine. Eur J Nucl Med Mol Imaging 30:519-524, 2003
48. Pirzkall A, Nelson SJ, McKnight TR, Takehashi MM, Li X, Graves EE, et al: Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy. Int J Radiat Oncol Biol Phys 53:1254-1264, 2002
49. Poptani H, Gupta RK, Roy R, Pandey R, Jain VK, Chhabra DK: Characterization of intracranial mass lesions with in vivo proton MR spectroscopy. AJNR 16:1593-1603, 1995
50. Preul MC, Caramanos Z, Collins DL, Villemure JG, Leblanc R, Olivier A, et al: Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nature Med 2:323-325, 1996
51. 1H spectra with LCModel. NMR Biomed 14:260-264, 2001
52. 18F]Fluoroethyl)-L-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes. Eur J Nucl Med Mol Imaging 29:1039-1046, 2002
53. Ribom D, Eriksson A, Hartman M, Engler H, Nilsson A, Långström B, et al: Positron emission tomography 11C-methionine and survival in patients with low-grade gliomas. Cancer 92:1541-1549, 2001
54. 11C-methionine positron emission tomography and proliferating cell nuclear antigen staining. Neurosurg Rev 22:210-214, 1999
55. Tedeschi G, Lundbom N, Raman R, Bonavista S, Duyn JH, Alger JR, et al: Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. J Neurosurg 87:516-524, 1997
56. 1H NMR spectroscopy in vivo and in vitro. J Comput Assist Tomogr 18:705-713, 1994
57. Vigneron D, Bollen A, McDermott M, Wald L, Day M, Moyher-Noworolski S, et al: Three-dimensional magnetic resonance spectroscopic imaging of histologically confirmed brain tumors. Magn Reson Imaging 19:89-101, 2001
58. Wallner KE, Galicich JH, Krol G, Arbit E, Malkin MG: Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 16:1405-1409, 1989
59. 11C] methionine uptake in brain tumours: initial results of a comparative study. Eur J Nucl Med 27:542-549, 2000
60. 18F]fluoroethyl)- L-tyrosine for tumor imaging. J Nucl Med 40:205-212, 1999
61. Wilden JN, Kelly PJ: CT computerised stereotactic biopsy for low density CT lesions presenting with epilepsy. J Neurol Neurosurg Psychiatry 50:1302-1305, 1987